Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2017-02-14 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PONT-DE-ROIDE-VERMONDANS (25150), Doubs
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE NERAC - PEGEOT is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PONT-DE-ROIDE-VERMONDANS (25150),
this company of category PME
shows in 2024 a net income positive of 165 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE NERAC - PEGEOT (SIREN 827712134)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
164 998 €
161 908 €
196 342 €
138 327 €
152 352 €
121 426 €
93 791 €
8 093 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE NERAC - PEGEOT generates positive net income of 165 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 8 k€ -> 165 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
164 998 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 26%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 62%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
25.545%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
61.876%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
6246.024
497.718
269.733
143.032
91.619
56.808
38.47
25.545
Financial autonomy
0.621
7.197
13.487
22.743
31.374
41.328
52.818
61.876
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
25.552024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good-11 pts over 3 years
In 2024, the debt ratio of PHARMACIE NERAC - PEGEOT (25.55) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
61.88%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+23 pts over 3 years
In 2024, the financial autonomy of PHARMACIE NERAC - PEGEOT (61.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 108.68. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
29.591
29.588
42.99
46.318
54.551
70.848
87.096
108.681
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
108.682024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch+8 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE NERAC - PEGEOT (108.68) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE NERAC - PEGEOT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE NERAC - PEGEOT is estimated at
2 303 494 €
(range 1 604 116€ - 3 446 158€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1604k€2303k€3446k€
2 303 494 €Range: 1 604 116€ - 3 446 158€
NAF 5 année 2024
Valuation method used
Net Income Multiple
164 998 €
×
14.0x
=2 303 494 €
Range: 1 604 117€ - 3 446 159€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE NERAC - PEGEOT with other companies in the same sector:
Frequently asked questions about PHARMACIE NERAC - PEGEOT
What is the revenue of PHARMACIE NERAC - PEGEOT ?
The revenue of PHARMACIE NERAC - PEGEOT is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE NERAC - PEGEOT profitable?
Yes, PHARMACIE NERAC - PEGEOT generated a net profit of 165 k€ in 2024.
Where is the headquarters of PHARMACIE NERAC - PEGEOT ?
The headquarters of PHARMACIE NERAC - PEGEOT is located in PONT-DE-ROIDE-VERMONDANS (25150), in the department Doubs.
Where to find the tax return of PHARMACIE NERAC - PEGEOT ?
The tax return of PHARMACIE NERAC - PEGEOT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE NERAC - PEGEOT operate?
PHARMACIE NERAC - PEGEOT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart